Literature DB >> 3508558

The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method.

R Bodmeier1, J W McGinity.   

Abstract

Several compounds such as caffeine, diazepam, hydrocortisone, progesterone, quinidine, quinidine hydrochloride, quinidine sulfate, and theophylline were evaluated for incorporation into poly(dl-lactide) (PLA) microspheres using the solvent evaporation technique. The process is generally limited to the entrapment of water-insoluble drugs. Adjustment of the pH of the aqueous phase to minimize drug solubility resulted in increased drug contents within the microspheres in the case of ionizable drugs. The release profile of quinidine from the microspheres was characterized by three different release phases, a lag time with no drug release, a burst effect of rapid drug release within a short period of time, and a slow release phase, respectively. The structure of the microsphere surface layer, which was a function of the pH of the aqueous phase at preparation, strongly influenced the rate and amount of drug released. Thermal analysis of quinidine-loaded microspheres revealed three thermal events, corresponding to the glass transition temperature of the polymer and to the recrystallization and melting of quinidine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3508558     DOI: 10.1023/a:1016419303727

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Lactic/glycolic acid polymers as narcotic antagonist delivery systems.

Authors:  A D Schwope; D L Wise; J F Howes
Journal:  Life Sci       Date:  1975-12-15       Impact factor: 5.037

2.  Long-acting delivery systems for narcotic antagonists. 1.

Authors:  J H Woodland; S Yolles; D A Blake; M Helrich; F J Meyer
Journal:  J Med Chem       Date:  1973-08       Impact factor: 7.446

Review 3.  Pharmaceutical applications of solid dispersion systems.

Authors:  W L Chiou; S Riegelman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

4.  Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics.

Authors:  N Wakiyama; K Juni; M Nakano
Journal:  Chem Pharm Bull (Tokyo)       Date:  1982-07       Impact factor: 1.645

5.  Development of polylactic/glycolic acid delivery systems for use in treatment of narcotic addiction.

Authors:  A D Schwope; D L Wise; J F Howes
Journal:  Natl Inst Drug Abuse Res Monogr Ser       Date:  1976-01

6.  Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres.

Authors:  L M Sanders; J S Kent; G I McRae; B H Vickery; T R Tice; D H Lewis
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

7.  Microencapsulation of astiban acid for the treatment of Schistosomiasis mansoni.

Authors:  P C Gopalratnam; N S Mason; R E Sparks
Journal:  Appl Biochem Biotechnol       Date:  1984       Impact factor: 2.926

8.  Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(d,l-lactide).

Authors:  K Suzuki; J C Price
Journal:  J Pharm Sci       Date:  1985-01       Impact factor: 3.534

9.  The formation and characterization of hydrocortisone-loaded poly((+/-)-lactide) microspheres.

Authors:  M Cavalier; J P Benoit; C Thies
Journal:  J Pharm Pharmacol       Date:  1986-04       Impact factor: 3.765

  9 in total
  28 in total

1.  Preparation of biodegradable microspheres and matrix devices containing naltrexone.

Authors:  Rassoul Dinarvand; Shadi H Moghadam; Leyla Mohammadyari-Fard; Fatemeh Atyabi
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

2.  Cephalexin microspheres for dairy mastitis: effect of preparation method and surfactant type on physicochemical properties of the microspheres.

Authors:  Wasana Chaisri; Wim E Hennink; Chadarat Ampasavate; Siriporn Okonogi
Journal:  AAPS PharmSciTech       Date:  2010-05-29       Impact factor: 3.246

3.  Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres.

Authors:  S Takada; T Kurokawa; K Miyazaki; S Iwasa; Y Ogawa
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

4.  Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery.

Authors:  Tapan Kumar Giri; Chhatrapal Choudhary; Amit Alexander; Hemant Badwaik; Dulal Krishna Tripathi
Journal:  Saudi Pharm J       Date:  2012-05-26       Impact factor: 4.330

5.  Improved activity of a new angiotensin receptor antagonist by an injectable spray-dried polymer microsphere preparation.

Authors:  F X Lacasse; P Hildgen; J Pérodin; E Escher; N C Phillips; J N McMullen
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

6.  A short term quality control tool for biodegradable microspheres.

Authors:  Susan D'Souza; Jabar A Faraj; Rossella Dorati; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2014-02-12       Impact factor: 3.246

7.  Nonaqueous gel for the transdermal delivery of a DTPA penta-ethyl ester prodrug.

Authors:  Yong Zhang; Matthew P Sadgrove; Katsuhiko Sueda; Yu-Tsai Yang; Erik K Pacyniak; John R Kagel; Brenda A Braun; William C Zamboni; Russell J Mumper; Michael Jay
Journal:  AAPS J       Date:  2013-02-07       Impact factor: 4.009

8.  Taxol encapsulation in poly(epsilon-caprolactone) microspheres.

Authors:  S K Dordunoo; J K Jackson; L A Arsenault; A M Oktaba; W L Hunter; H M Burt
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Influence of suspension stabilisers on the delivery of protein-loaded porous poly (DL-lactide-co-glycolide) (PLGA) microparticles via pressurised metered dose inhaler (pMDI).

Authors:  Elizabeth Cocks; Satyanarayana Somavarapu; Oya Alpar; David Greenleaf
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

10.  The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique.

Authors:  H Jeffery; S S Davis; D T O'Hagan
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.